URGN·M96088105·US·equity·Healthcare - Biotechnology-Activist
URGN (UROGEN PHARMA LTD) is held by 92 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($81.7M), BlackRock, Inc. ($51.2M), TORONTO DOMINION BANK ($47M). Net institutional sentiment: Mixed.
See how URGN's score breaks down across 4 SEC sources
Showing 1-20 of 107
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer